Multicenter Double Blind, Parallel-group Phase 2/3 Trial, to Study Raloxifene in Adult COVID-19 Patients.
NCT05172050
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
61
Enrollment
INDUSTRY
Sponsor class
Conditions
SARS CoV 2 Infection
Interventions
DRUG:
Raloxifene
OTHER:
Placebo
Sponsor
Dompé Farmaceutici S.p.A